What happens when you take propranolol with st. john's wort?
Propranolol is a non-selective beta-blocker prescribed for hypertension, migraine prevention, essential tremor, performance anxiety, and certain heart rhythm problems. It is metabolized in the liver primarily by CYP1A2 and CYP2D6, with smaller contributions from CYP2C19, before being cleared by the kidneys. St. John's Wort (Hypericum perforatum) is an herbal extract widely sold for mild depression and anxiety. One of its active constituents, hyperforin, binds to the pregnane X receptor in the liver and switches on transcription of multiple drug-metabolizing enzymes, including CYP3A4, CYP1A2, CYP2C9, and CYP2C19, along with the drug transporter P-glycoprotein.
When propranolol and St. John's Wort are taken together for more than about ten days, the induced enzymes break down propranolol faster than usual. Plasma concentrations drop, and the drug's intended effect, slowing heart rate and lowering blood pressure, becomes weaker. The same mechanism has been documented to reduce levels of dozens of CYP3A4-metabolized drugs by 40 to 80 percent in formal interaction studies.
A published case report describes a glaucoma patient on topical beta-blocker drops whose intraocular pressure rose while taking St. John's Wort and returned to target when the herb was stopped. While the case involves topical rather than systemic beta-blockade, the mechanism, accelerated beta-blocker metabolism, points to the same risk for oral propranolol.
Why is this important?
Propranolol is often prescribed for conditions where loss of effect is immediately dangerous. In patients on propranolol for arrhythmia control or post-heart-attack secondary prevention, a quiet drop in drug levels can lead to breakthrough heart rhythm events. In patients on propranolol for hypertension, the cost is poorer blood pressure control. In migraine and tremor patients, the cost is the return of symptoms.
The risk is hidden because St. John's Wort is a supplement and patients often do not mention it to their prescribers. Pharmacists are not always told either, because the herb is sold off the shelf at grocery stores and health food shops alongside vitamins. Even highly engaged patients may not know that an herbal product can substantially change how their prescription drug works.
The induction effect builds over about 10 to 14 days of regular St. John's Wort use and washes out over a similar window after stopping. This means that starting or stopping the herb shifts propranolol levels in slow motion, and the change can be missed unless the prescriber is monitoring closely.
What should you do?
If you have been told to take propranolol for any reason and you are also taking St. John's Wort, tell your prescriber as soon as possible. Do not stop St. John's Wort abruptly without guidance, especially if you started it for depression; rebound depressive symptoms are a concern in some users, and any reasonable plan should taper the herb while monitoring the underlying mood condition.
If you are starting propranolol for the first time, tell your prescriber every supplement and herbal product you take. St. John's Wort is the most important to flag, but the same enzyme-induction risk applies to other inducers including rifampin, carbamazepine, phenytoin, and high-dose chronic alcohol. If you do not currently take St. John's Wort, do not start it during propranolol therapy.
If propranolol stops working as well as it used to, ask yourself what has changed. New supplements, herbal teas, weight loss products, mood support stacks, and even some bodybuilding supplements can contain St. John's Wort or other CYP inducers. Bring all containers to your prescriber visit; reading labels yourself is harder than it sounds because many botanical names are obscure.
If you and your prescriber decide to keep both, plan for closer monitoring. That may mean home blood pressure logs, more frequent office visits, or in some cases dose adjustments. Once St. John's Wort is stopped, monitor for the reverse problem: as enzyme induction fades over two weeks, propranolol levels rise back toward baseline, and a patient whose dose was raised to compensate may suddenly be over-dosed.
Which specific products are affected?
Propranolol is sold as Inderal, Inderal LA, InnoPran XL, and Hemangeol, with many generics. The CYP induction effect of St. John's Wort affects all forms equally.
St. John's Wort is sold under many brand names and as bulk dried herb, capsules, tinctures, and teas. Most clinical interactions have been studied with standardized extracts containing 0.3 percent hypericin or 3 to 6 percent hyperforin, taken at 300 mg three times daily. Low-hyperforin preparations have weaker enzyme-induction effects but are not reliably distinguished on product labels, so the safest assumption is that any St. John's Wort product is an inducer.
Other CYP-induced beta-blockers are at similar risk, with the magnitude depending on the metabolic pathways involved. Metoprolol (CYP2D6 primarily) is somewhat less induced because CYP2D6 is not strongly responsive to St. John's Wort. Carvedilol, which is metabolized by CYP2D6, CYP2C9, and CYP3A4, is more clearly affected.
The bottom line
St. John's Wort speeds up the breakdown of propranolol by inducing the liver enzymes that metabolize the drug. The combination can quietly reduce propranolol's blood pressure, heart rate, and migraine-preventing effects, with the change building over about two weeks. Tell your prescriber if you take both, do not start St. John's Wort while on propranolol, and consult before stopping the herb so they can plan for the reverse-direction change in drug levels.